|
Haemostatic parameters in pztients with BIH and controls. Values are expressed as main ± SD |
|||
| Patients |
Healthy Controls |
P value |
|
|
|
|||
| PT(sec) |
12 ± 0,5 |
11,5 ± 0,8 |
0.18, ns |
| aPTT (sec) |
30 ± 2,5 |
31,5 ± 3,4 |
0.09, ns |
| Fibrinogen (mg/dl) |
340 ± 80,7 |
360 ± 68,2 |
0.32, ns |
| ATIII (%) |
72 ± 16,5 |
76 ± 14,7 |
0.34, ns |
| PG (%) |
80 ± 14,7 |
74,5 ± 15,2 |
0.19, ns |
| t-PA(ng/ml) |
6,8 ± 3,7 |
7,5 ± 4,8 |
0.58, ns |
| PAI-l(ng/ml) |
45.7 ± 12.5 |
8.5 ± 6.7 |
< 0.0001, s |
| FPA (ng/ml) |
8.7 ± 2.5 |
2.2 ± 1.25 |
< 0.0001, s |
| F1+2 (nM/l) |
5.7 ± 1.15 |
0.45 ± 0.35 |
0.0001, s |
| D-dimers (ng/ml) |
375 ± 65 |
225 ± 75 |
< 0.0001, s |
| PC(%) |
64 ± 7.5 |
87 ± 14.5 |
< 0.0001, s |
| PS (%) |
97 ± 23 |
103 ± 12 |
0.16, ns |
| Aβ2IgM (UM/l) |
14.5 ± 6.8 |
0.38 ± 0.25 |
< 0.0001, s |
| Aβ2IgG(UG/l) |
22.5 ± 11.5 |
0.58 ± 0.30 |
< 0.0001, s |
|
Prothrombin Time: PT; Activated Partial Prothrombin Time: aPTT; Antithrombin: AT III, Plasminogen: PG; tissue-Plasminogen Activator; t-PA, Plasminogen Activator Inhibitor type-1: PAI-1; Fibrinopeptide-A: FPA; Prothrombin Fragment 1+2: F1+2; Protein C activity: PC; Protein S activity: PS; IgM anticardiolipin antibodies Ig M and Ig G: Aβ2IgM and Aβ2IgG; s: significant; ns: not significant. | |||
De Lucia et al. Thrombosis Journal 2006 4:21 doi:10.1186/1477-9560-4-21 |
|||